Increased peripheral benzodiazepine binding sites in the brain of patients with Huntington's disease
- 1 January 1998
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 241 (1) , 53-56
- https://doi.org/10.1016/s0304-3940(97)00967-1
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Peripheral benzodiazepine receptor modulation with phagocyte differentiationBiochemical Pharmacology, 1993
- Do defecs in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?Trends in Neurosciences, 1993
- Peripheral type benzodiazepine binding sites following transient forebrain ischemia in the rat: effect of neuroprotective drugsBrain Research, 1991
- Peripheral benzodiazepine binding sites in Alzheimer's disease frontal and temporal cortexNeurobiology of Aging, 1991
- Increase inω3 (peripheral type benzodiazepine) binding sites in the rat cortex and striatum after local injection of interleukin-1, tumour necrosis factor-α and lipopolysaccharideBrain Research, 1991
- Diazepam binding inhibitor (DBI): A peptide with multiple biological actionsLife Sciences, 1991
- The quantification of brain lesions with anω3 site ligand: a critical analysis of animal models of cerebral ischaemia and neurodegenerationBrain Research, 1990
- Increase in diazepam binding inhibitor-like immunoreactivity(51–70) in Huntington's diseaseJournal of the Neurological Sciences, 1988
- Peripheral type benzodiazepine binding sites are a sensitive indirect index of neuronal damageBrain Research, 1987
- Replication of the neurochemical characteristics of Huntington's disease by quinolinic acidNature, 1986